文献速递关节外科

全膝关节置换术后KOOS的疾病特异性最小临床重要差异与患者可接受症状状态阈值

Diagnosis-Specific Thresholds of the Minimal Clinically Important Difference and Patient Acceptable Symptom State for KOOS After Total Knee Arthroplasty.
PubMed 文献 · J Bone Joint Surg Am · 2024-02-21

该前瞻性队列纳入6,778例行初次全膝关节置换术的患者,其中5,186例诊断为骨关节炎,平均年龄67.0岁,女性占59.9%,白人占80.4%。采用分布法估计最小可检测变化(MDC)和最小临床重要差异(MCID),采用锚定法估计患者可接受症状状态(PASS)阈值,对应术后1年满意度问题的回答。骨关节炎组KOOS疼痛、PS和JR的MCID阈值分别为7.9、8.0和6.7,PASS阈值分别为77.7、70.3和70.7。

要点

  • 骨关节炎组KOOS疼痛、PS、JR的MCID阈值分别为7.9、8.0、6.7。
  • 骨关节炎组KOOS疼痛、PS、JR的PASS阈值分别为77.7、70.3、70.7。
  • 达到MCID的患者比例:KOOS疼痛95%、PS 88%、JR 94%。

核心结论

  • 本研究为骨关节炎患者行全膝关节置换术后提供了KOOS疼痛、PS和JR的MCID、MDC和PASS阈值。
  • 本文建立的疾病特异性指标可作为临床有意义术后改善的基准。
  • 未来的研究和质量评估在评价全膝关节置换术后结局时应使用这些骨关节炎特异性阈值。

研究设计与样本

  • 前瞻性队列研究,纳入6,778例行初次全膝关节置换术的患者。
  • 完成1年随访的患者数:KOOS疼痛5,316例,KOOS PS 5,018例,KOOS JR 4,033例。
  • 骨关节炎诊断组5,186例,平均年龄67.0岁,女性占59.9%,白人占80.4%。
  • 采用分布法估计疾病特异性MDC和MCID,采用锚定法估计PASS值,锚定为术后1年满意度问题的回答。
  • 证据等级:预后Level II。

主要发现

  • 骨关节炎组MCID阈值:KOOS疼痛7.9,KOOS PS 8.0,KOOS JR 6.7。
  • 达到MCID阈值的患者比例:KOOS疼痛95%,KOOS PS 88%,KOOS JR 94%。
  • MDC 80%至95%置信区间:KOOS疼痛9.1至14.0,KOOS PS 9.2至14.1,KOOS JR 7.7至11.8。
  • 骨关节炎组PASS阈值:KOOS疼痛77.7(73%患者达到),KOOS PS 70.3(68%患者达到),KOOS JR 70.7(70%患者达到)。

关键数值与推荐

  • 骨关节炎组MCID阈值:KOOS疼痛7.9,KOOS PS 8.0,KOOS JR 6.7。
  • 骨关节炎组PASS阈值:KOOS疼痛77.7,KOOS PS 70.3,KOOS JR 70.7。
  • MDC 80%至95%置信区间:KOOS疼痛9.1至14.0,KOOS PS 9.2至14.1,KOOS JR 7.7至11.8。

临床怎么用

  • 本文建立的骨关节炎特异性阈值可作为全膝关节置换术后临床有意义改善的基准。
  • 未来的研究和质量评估在评价全膝关节置换术后结局时应使用这些骨关节炎特异性阈值。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UPDATE: This article was updated on May 1, 2024 because of a previous error, which was discovered after the preliminary version of the article was posted online. The byline that had read "Ahmed K. Emara, MD 1 *, Ignacio Pasqualini, MD 1 *, Alison K. Klika, MS 1 , Melissa N. Orr, BS 1 , Pedro J. Rullán, MD 1 , Nicolas S. Piuzzi, MD 1 , and the Cleveland Clinic Arthroplasty Group†" now reads "Ahmed K. Emara, MD 1 *, Ignacio Pasqualini, MD 1 *, Yuxuan Jin, MS 1 , Alison K. Klika, MS 1 , Melissa N. Orr, BS 1 , Pedro J. Rullán, MD 1 , Nicolas S. Piuzzi, MD 1 , and the Cleveland Clinic Arthroplasty Group†". BACKGROUND: Literature-reported minimal clinically important difference (MCID) and patient acceptable symptom state (PASS) thresholds for patient-reported outcome measures demonstrate marked variability. The purpose of this study was to determine the minimal detectable change (MDC), MCID, and PASS thresholds for the Knee injury and Osteoarthritis Outcome Score (KOOS) Pain subdomain, Physical Function Short Form (PS), and Joint Replacement (JR) among patients with osteoarthritis (OA) who underwent primary total knee arthroplasty (TKA). METHODS: A prospective cohort of 6,778 patients who underwent primary TKA was analyzed. Overall, 1-year follow-up was completed by 5,316 patients for the KOOS Pain, 5,018 patients for the KOOS PS, and 4,033 patients for the KOOS JR. A total of 5,186 patients had an OA diagnosis; this group had an average age of 67.0 years and was 59.9% female and 80.4% White. Diagnosis-specific MDCs and MCIDs were estimated with use of a distribution-based approach. PASS values were estimated with use of an anchor-based approach, which corresponded to a response to a satisfaction question at 1 year postoperatively. RESULTS: The MCID thresholds for the OA group were 7.9 for the KOOS Pain, 8.0 for the KOOS PS, and 6.7 for the KOOS JR. A high percentage of patients achieved the MCID threshold for each outcome measure (KOOS Pain, 95%; KOOS PS, 88%; and KOOS JR, 94%). The MDC 80% to 95% confidence intervals ranged from 9.1 to 14.0 for the KOOS Pain, 9.2 to 14.1 for the KOOS PS, and 7.7 to 11.8 for the KOOS JR. The PASS thresholds for the OA group were 77.7 for the KOOS Pain (achieved by 73% of patients), 70.3 for the KOOS PS (achieved by 68% of patients), and 70.7 for the KOOS JR (achieved by 70% of patients). CONCLUSIONS: The present study provided useful MCID, MDC, and PASS thresholds for the KOOS Pain, PS, and JR for patients with OA. The diagnosis-specific metrics established herein can serve as benchmarks for clinically meaningful postoperative improvement. Future research and quality assessments should utilize these OA-specific thresholds when evaluating outcomes following TKA. Doing so will enable more accurate determinations of operative success and improvements in patient-centered care. LEVEL OF EVIDENCE: Prognostic Level II . See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Emara AK, Pasqualini I, Jin Y, et al. Diagnosis-Specific Thresholds of the Minimal Clinically Important Difference and Patient Acceptable Symptom State for KOOS After Total Knee Arthroplasty. J Bone Joint Surg Am. 2024. PMID: 38381811. doi:10.2106/JBJS.23.00027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。